You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Head and Neck Squamous Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

Not yet recruiting
  • Head Neck
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Center
Sep 14, 2023

HPV-Related Squamous Cell Carcinoma, HNSCC Trial in London (VB10.16, Pembrolizumab)

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • HNSCC
  • London, United Kingdom
    East and North Hertfordshire NHS Trust Mount Vernon Hospital
Aug 24, 2023

Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Winston-Salem (Pembrolizumab,

Recruiting
  • Head Neck Cancer
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health Sciences
Aug 8, 2022

Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Carrilizumab, bevacizumab,capecitabine
  • (no location specified)
Jul 20, 2023

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

Recruiting
  • Head and Neck Squamous Cell Carcinoma
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Aug 22, 2023

    Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • PET/CT
    • Neck dissection
    • (no location specified)
    Jan 31, 2023

    Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

    Not yet recruiting
    • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
    • Guangzhou, Guangdong, China
      Sun Yat-sen University
    Oct 24, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

    Not yet recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Mar 20, 2023

    Head and Neck Squamous-cell Carcinoma

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +2 more
      • (no location specified)
      Nov 5, 2023

      Needs and Preferences of Patients With Head-neck Cutaneous SCC

      Active, not recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +10 more
      • Regular care with additional administration of a semi-structured interview
      • Maastricht, Netherlands
        Maastricht University Medical Center+
      Sep 13, 2023

      Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +3 more
      • Guangzhou, Guangdong, China
      • +4 more
      Nov 16, 2023

      Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Head and Neck Cancer
      • (no location specified)
      Jun 9, 2023

      Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Aug 17, 2023

      Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Locally Advanced Operable
      • Guangzhou, Guangdong, China
      • +1 more
      Sep 4, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Nab paclitaxel
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital
      Aug 24, 2023

      Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

      Not yet recruiting
      • Metastatic Head-and-neck Squamous-cell Carcinoma
      • Recurrent Head and Neck Squamous Cell Carcinoma
      • Ficlatuzumab
      • +2 more
      • (no location specified)
      Sep 26, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Zanzalintinib, Zanzalintinib-matched Placebo, Pembrolizumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Oct 9, 2023

      Prognostic Immune Biomarkers in HNSCC

      Completed
      • Head and Neck Cancer
      • Squamous Cell Carcinoma
      • Tumour immunoprofile evaluation
      • Ostrava, Moravian-Silesian Region, Czechia
        University Hospital Ostrava
      Jul 3, 2023

      Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity
      • +3 more
      • Eliminating RT to the elective neck
      • RT standard of care
      • Erlangen, Bavaria, Germany
        Universitätsklinikum Erlangen, Strahlenklinik
      Sep 8, 2023

      Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma (HNSCC)
      • Netopitam Palonosetron capsules and dexamethasone
      • Chengdu, Sichuan, China
        Sichuan Cancer Hospital and Research Institute
      Oct 22, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Penpulimab injection
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
      Oct 7, 2023

      Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

      Not yet recruiting
      • Recurrent Head and Neck Cancer
      • +5 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 30, 2023

      Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head

      Recruiting
      • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
      • +4 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jan 19, 2023

      Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

      Not yet recruiting
      • Metastatic Melanoma
      • Head and Neck Squamous Cell Carcinoma
      • Portland, Oregon
        Providence Portland Medical Center
      Jun 19, 2023